Literature DB >> 27116009

Impact of selective digestive decontamination on respiratory tract Candida among patients with suspected ventilator-associated pneumonia. A meta-analysis.

J C Hurley1,2,3.   

Abstract

The purpose here is to establish the incidence of respiratory tract colonization with Candida (RT Candida) among ICU patients receiving mechanical ventilation within studies in the literature. Also of interest is its relationship with candidemia and the relative importance of topical antibiotic (TA) use as within studies of selective digestive decontamination (SDD) versus other candidate risk factors towards it. The incidence of RT Candida was extracted from component (control and intervention) groups decanted from studies of various TA and non-TA ICU infection prevention methods with summary estimates derived using random effects. A benchmark RT Candida incidence to provide overarching calibration was derived using (observational) groups from studies without any prevention method under study. A multi-level regression model of group level data was undertaken using generalized estimating equation (GEE) methods. RT Candida data were sourced from 113 studies. The benchmark RT Candida incidence is 1.3; 0.9-1.8 % (mean and 95 % confidence intervals). Membership of a concurrent control group of a study of SDD (p = 0.02), the group-wide presence of candidemia risk factors (p < 0.001), and proportion of trauma admissions (p = 0.004), but neither the year of study publication, nor membership of any other component group, nor the mode of respiratory sampling are predictive of the RT Candida incidence. RT Candida and candidemia incidences are correlated. RT Candida incidence can serve as a basis for benchmarking. Several relationships have been identified. The increased incidence among concurrent control groups of SDD studies cannot be appreciated in any single study examined in isolation.

Entities:  

Mesh:

Year:  2016        PMID: 27116009     DOI: 10.1007/s10096-016-2643-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  150 in total

1.  Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial.

Authors:  Patrique Segers; Ron G H Speekenbrink; Dirk T Ubbink; Marc L van Ogtrop; Bas A de Mol
Journal:  JAMA       Date:  2006-11-22       Impact factor: 56.272

2.  Mortality associated with late-onset pneumonia in the intensive care unit: results of a multi-center cohort study.

Authors:  Pierre Moine; Jean-François Timsit; Arnaud De Lassence; Gilles Troché; Jean-Philippe Fosse; Corrine Alberti; Yves Cohen
Journal:  Intensive Care Med       Date:  2002-01-16       Impact factor: 17.440

3.  Nosocomial pneumonia in patients with acute respiratory distress syndrome.

Authors:  J Chastre; J L Trouillet; A Vuagnat; M L Joly-Guillou; H Clavier; M C Dombret; C Gibert
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

Review 4.  Ventilator-associated pneumonia prevention methods using topical antibiotics: herd protection or herd peril?

Authors:  James C Hurley
Journal:  Chest       Date:  2014-10       Impact factor: 9.410

5.  The effect of acidified enteral feeds on gastric colonization in critically ill patients: results of a multicenter randomized trial. Canadian Critical Care Trials Group.

Authors:  D K Heyland; D J Cook; P S Schoenfeld; A Frietag; J Varon; G Wood
Journal:  Crit Care Med       Date:  1999-11       Impact factor: 7.598

6.  Selective decontamination of subglottic area in mechanically ventilated patients with multiple trauma.

Authors:  Ioannis Pneumatikos; Vassilios Koulouras; Christodoulos Nathanail; Diana Goe; George Nakos
Journal:  Intensive Care Med       Date:  2002-03-06       Impact factor: 17.440

7.  Incidence and risk factors of pneumonia acquired in intensive care units. Results from a multicenter prospective study on 996 patients. European Cooperative Group on Nosocomial Pneumonia.

Authors:  S Chevret; M Hemmer; J Carlet; M Langer
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

8.  Short-term decline in all-cause acquired infections with the routine use of a decontamination regimen combining topical polymyxin, tobramycin, and amphotericin B with mupirocin and chlorhexidine in the ICU: a single-center experience.

Authors:  Christophe Camus; Sylvain Salomon; Claire Bouchigny; Arnaud Gacouin; Sylvain Lavoué; Pierre-Yves Donnio; Loic Javaudin; Jean-Marc Chapplain; Fabrice Uhel; Yves Le Tulzo; Eric Bellissant
Journal:  Crit Care Med       Date:  2014-05       Impact factor: 7.598

9.  A controlled trial of selective decontamination of the digestive tract in intensive care and its effect on nosocomial infection.

Authors:  R Winter; H Humphreys; A Pick; A P MacGowan; S M Willatts; D C Speller
Journal:  J Antimicrob Chemother       Date:  1992-07       Impact factor: 5.790

10.  Candida pneumonia in intensive care unit?

Authors:  Ronny M Schnabel; Catharina F Linssen; Nele Guion; Walther N van Mook; Dennis C Bergmans
Journal:  Open Forum Infect Dis       Date:  2014-05-27       Impact factor: 3.835

View more
  7 in total

1.  Incidences of Pseudomonas aeruginosa-Associated Ventilator-Associated Pneumonia within Studies of Respiratory Tract Applications of Polymyxin: Testing the Stoutenbeek Concurrency Postulates.

Authors:  James C Hurley
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

2.  Unusually High Incidences of Staphylococcus aureus Infection within Studies of Ventilator Associated Pneumonia Prevention Using Topical Antibiotics: Benchmarking the Evidence Base.

Authors:  James C Hurley
Journal:  Microorganisms       Date:  2018-01-04

3.  Unusually High Incidences of Pseudomonas Bacteremias Within Topical Polymyxin-Based Decolonization Studies of Mechanically Ventilated Patients: Benchmarking the Literature.

Authors:  James C Hurley
Journal:  Open Forum Infect Dis       Date:  2018-10-10       Impact factor: 3.835

Review 4.  Conventional Antifungals for Invasive Infections Delivered by Unconventional Methods; Aerosols, Irrigants, Directed Injections and Impregnated Cement.

Authors:  Richard H Drew; John R Perfect
Journal:  J Fungi (Basel)       Date:  2022-02-21

5.  Candida and the Gram-positive trio: testing the vibe in the ICU patient microbiome using structural equation modelling of literature derived data.

Authors:  James C Hurley
Journal:  Emerg Themes Epidemiol       Date:  2022-08-18

6.  Candida-Acinetobacter-Pseudomonas Interaction Modelled within 286 ICU Infection Prevention Studies.

Authors:  James C Hurley
Journal:  J Fungi (Basel)       Date:  2020-10-27

7.  Structural equation modelling the relationship between anti-fungal prophylaxis and Pseudomonas bacteremia in ICU patients.

Authors:  James C Hurley
Journal:  Intensive Care Med Exp       Date:  2022-01-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.